The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy ...
A team of researchers led by Karina Xavier has uncovered a promising new live biotherapeutic agent that may redefine how the ...
Smithsonian Magazine on MSN
The High-Stakes Quest to Make Snakebites Survivable Took Leaps Forward This Year, With Promising New Avenues to Safer Antivenoms
A wave of fresh science is challenging a century-old treatment and offering hope to the people snakebites harm most—often far ...
Verzenio monotherapy provided clinical benefits to 33% of patients with HR-positive, HER2-negative breast cancer after prior ...
Hair masks are like intensive therapy sessions for your [midsections] and ends. Regular conditioners and leave-ins are great ...
Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest ...
Kyverna Therapeutics looks all the more likely to win the first FDA approval for a CAR-T therapy in an autoimmune disease after a registrational trial showed “highly statistically significant” ...
“Patients can expect mild to moderate pain and swelling for a few days after the dissolving treatment,” says Dr. Sung. And it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback